Financhill
Back

New York Times Vs. Novo Nordisk AS Industry Stock Comparison

Buy
57

NYT
New York Times

Last Price:
$52.87
Seasonality Move:
6.36%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Buy
57
New York Times (NYT) is a Buy

Is New York Times a Buy, Sell or Hold?

  • The current New York Times [NYT] share price is $52.87. The Score for NYT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • NYT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NYT Stock Price Chart

What is New York Times's stock price today?

  • The New York Times share price today is $52.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NYT is experiencing selling pressure, which indicates risk of future bearish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

NYT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 39.97 Sell
Chaikin Money Flow: -2610197 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.98 - 55.46) Sell
Bollinger Bands (100): (53.35 - 55.63) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

NYT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.37 Sell
20-day SMA: 54.66 Sell
50-day SMA: 54.7 Sell
200-day SMA: 51.12 Buy
8-day EMA: 54.03 Sell
20-day EMA: 54.42 Sell
50-day EMA: 54.49 Sell
200-day EMA: 51.69 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

New York Times Earnings Growth & NYT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $0.19 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

New York Times Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):